In an age of media saturation and information overload, it is becoming more difficult to discern real health and safety signals from background noise.
In Diabetes Voice, Prof. Rury Holman argues that the future of medicine relies on effective clinical trials and competent reporting.
A flood of exploratory analyses of emerging large-scale medical record databases and registries may have highlighted interesting issues, but it has also brought with it a need to sift the believable from the opportunistic.
Sadly, many findings are reported by the media without suitable rigour, often giving equal - or greater - prominence to unsubstantiated exploratory findings than they do to robust results from properly designed and conducted trials.
Ultimately, Prof. Holman argues, it is the research community that has a duty of care to report trials, studies and 'incidental' findings in context.
Read the full article in Diabetes Care.